India, May 14 -- MDxHealth SA (MDXH), a commercial-stage precision diagnostics company, on Wednesday reported its first quarter financial results.
Shares fell by 44.63% in the pre-market on Thursday.
Q1 2026:
MDxHealth recorded net revenues of $27.38 million, rising 13% from the $24.29 million reported a year ago.
The gross profits amounted to $16.61 million, rising 7% from the $15.50 million gained in the first quarter of 2025.
The company saw a net loss of $8.87 million, or $0.17 per share, 4% lesser than the $9.21 million, or $0.19 per share reported in the previous year.
Adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) were a loss of $4.34 million in the first quarter, 226% higher when compared to t...